71
views
0
recommends
+1 Recommend
0 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mitochondrial fission induced by platelet-derived growth factor regulates vascular smooth muscle cell bioenergetics and cell proliferation

      research-article
      a , a , b , c , *
      Redox Biology
      Elsevier
      ADP, adenine dinucleotide phosphate, ATP5A1, ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, ATP5B, ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide, CPT1, carnitine palmitoyl transferase 1, DMEM, Delbucco's Eagle Modified Medium, Drp1, dynamin-related protein 1, EDTA, ethylenediaminetetraacetic acid, EGTA, ethylene glycol tetraacetic acid, MOPS, 3-(N-morpholino)propanesulfonic acid, Fis1, mitochondrial fission 1 protein, FCCP, Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, FBS, fetal bovine serum, HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, NDUFB8, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, NP-40, noniodet P40, LC3, (microtubule-associated protein 1 light chain 3), Opa1, optic atrophy 1, PCNA, proliferating cell nuclear antigen, PDGF-BB, platelet-derived growth factor-BB, PVDF, polyvinylidene fluoride, SDS, sodium dodecyl sulfate, SDHB, succinate dehydrogenase subunit B, TMPD, N,N,N′,N′-tetramethyl-p-phenylenediamine, VSMC, vascular smooth muscle cells, Metabolism, Oxidative phosphorylation, Restenosis, Atherosclerosis, Fusion, Extracellular flux

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Vascular smooth muscle cells (VSMCs) develop a highly proliferative and synthetic phenotype in arterial diseases. Because such phenotypic changes are likely integrated with the energetic state of the cell, we hypothesized that changes in cellular metabolism regulate VSMC plasticity. VSMCs were exposed to platelet-derived growth factor-BB (PDGF) and changes in mitochondrial morphology, proliferation, contractile protein expression, and mitochondrial metabolism were examined. Exposure of VSMCs to PDGF resulted in mitochondrial fragmentation and a 50% decrease in the abundance of mitofusin 2. Synthetic VSMCs demonstrated a 20% decrease in glucose oxidation, which was accompanied by an increase in fatty acid oxidation. Results of mitochondrial function assays in permeabilized cells showed few changes due to PDGF treatment in mitochondrial respiratory chain capacity and coupling. Treatment of VSMCs with Mdivi-1—an inhibitor of mitochondrial fission—inhibited PDGF-induced mitochondrial fragmentation by 50% and abolished increases in cell proliferation; however, it failed to prevent PDGF-mediated activation of autophagy and removal of contractile proteins. In addition, treatment with Mdivi-1 reversed changes in fatty acid and glucose oxidation associated with the synthetic phenotype. These results suggest that changes in mitochondrial morphology and bioenergetics underlie the hyperproliferative features of the synthetic VSMC phenotype, but do not affect the degradation of contractile proteins. Mitochondrial fragmentation occurring during the transition to the synthetic phenotype could be a therapeutic target for hyperproliferative vascular disorders.

          Graphical abstract

          Highlights

          • PDGF promotes mitochondrial fragmentation in vascular smooth muscle cells.

          • PDGF increases metabolic reliance on fatty acids.

          • Mitochondrial fragmentation regulates proliferation and bioenergetics.

          • PDGF-induced bioenergetic and autophagic responses regulate de-differentiation.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization.

          Mitochondrial fusion and division play important roles in the regulation of apoptosis. Mitochondrial fusion proteins attenuate apoptosis by inhibiting release of cytochrome c from mitochondria, in part by controlling cristae structures. Mitochondrial division promotes apoptosis by an unknown mechanism. We addressed how division proteins regulate apoptosis using inhibitors of mitochondrial division identified in a chemical screen. The most efficacious inhibitor, mdivi-1 (for mitochondrial division inhibitor) attenuates mitochondrial division in yeast and mammalian cells by selectively inhibiting the mitochondrial division dynamin. In cells, mdivi-1 retards apoptosis by inhibiting mitochondrial outer membrane permeabilization. In vitro, mdivi-1 potently blocks Bid-activated Bax/Bak-dependent cytochrome c release from mitochondria. These data indicate the mitochondrial division dynamin directly regulates mitochondrial outer membrane permeabilization independent of Drp1-mediated division. Our findings raise the interesting possibility that mdivi-1 represents a class of therapeutics for stroke, myocardial infarction, and neurodegenerative diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Smooth muscle cell phenotypic switching in atherosclerosis.

            Smooth muscle cells (SMCs) possess remarkable phenotypic plasticity that allows rapid adaptation to fluctuating environmental cues, including during development and progression of vascular diseases such as atherosclerosis. Although much is known regarding factors and mechanisms that control SMC phenotypic plasticity in cultured cells, our knowledge of the mechanisms controlling SMC phenotypic switching in vivo is far from complete. Indeed, the lack of definitive SMC lineage-tracing studies in the context of atherosclerosis, and difficulties in identifying phenotypically modulated SMCs within lesions that have down-regulated typical SMC marker genes, and/or activated expression of markers of alternative cell types including macrophages, raise major questions regarding the contributions of SMCs at all stages of atherogenesis. The goal of this review is to rigorously evaluate the current state of our knowledge regarding possible phenotypes exhibited by SMCs within atherosclerotic lesions and the factors and mechanisms that may control these phenotypic transitions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles.

              Vascular smooth muscle cells (VSMCs) are the stromal cells of the vascular wall, continually exposed to mechanical signals and biochemical components generated in the blood compartment. They are involved in all the physiological functions and the pathological changes taking place in the vascular wall. Owing to their contractile tonus, VSMCs of resistance vessels participate in the regulation of blood pressure and also in hypertension. VSMCs of conduit arteries respond to hypertension-induced increases in wall stress by an increase in cell protein synthesis (hypertrophy) and extracellular matrix secretion. These responses are mediated by complex signalling pathways, mainly involving RhoA and extracellular signal-regulated kinase1/2. Serum response factor and miRNA expression represent main mechanisms controlling the pattern of gene expression. Ageing also induces VSMC phenotypic modulation that could have influence on cell senescence and loss of plasticity and reprogramming. In the early stages of human atheroma, VSMCs support the lipid overload. Endocytosis/phagocytosis of modified low-density lipoproteins, free cholesterol, microvesicles, and apoptotic cells by VSMCs plays a major role in the progression of atheroma. Migration and proliferation of VSMCs in the intima also participate in plaque progression. The medial VSMC is the organizer of the inwardly directed angiogenic response arising from the adventitia by overexpressing vascular endothelial growth factor in response to lipid-stimulated peroxisome proliferator-activated receptor-γ, and probably also the organizer of the adventitial immune response by secreting chemokines. VSMCs are also involved in the response to proteolytic injury via their ability to activate blood-borne proteases, to secrete antiproteases, and to clear protease/antiprotease complexes.
                Bookmark

                Author and article information

                Contributors
                Journal
                Redox Biol
                Redox Biol
                Redox Biology
                Elsevier
                2213-2317
                7 November 2013
                7 November 2013
                2013
                : 1
                : 1
                : 542-551
                Affiliations
                [a ]Diabetes and Obesity Center, Institute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY 40202, USA
                [b ]Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, KY 40202, USA
                [c ]Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40202, USA
                Author notes
                [* ]Correspondence to: Diabetes and Obesity Center, Institute of Molecular Cardiology, University of Louisville School of Medicine, Delia Baxter Building, Room 404A, 580 South Preston Street, Louisville, KY 40202 United States. Tel.: +1 502 852 1015; fax: +1 502 852 3663. bradford.hill@ 123456louisville.edu hillbrad@ 123456hotmail.com
                Article
                S2213-2317(13)00080-3
                10.1016/j.redox.2013.10.011
                3836280
                24273737
                d86a5458-6f7b-4548-bad0-607cd1c8a8e5
                © 2013 The Authors

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 26 October 2013
                : 30 October 2013
                : 31 October 2013
                Categories
                Article

                adp, adenine dinucleotide phosphate,atp5a1, atp synthase, h+ transporting, mitochondrial f1 complex, alpha subunit 1,atp5b, atp synthase, h+ transporting, mitochondrial f1 complex, beta polypeptide,cpt1, carnitine palmitoyl transferase 1,dmem, delbucco's eagle modified medium,drp1, dynamin-related protein 1,edta, ethylenediaminetetraacetic acid,egta, ethylene glycol tetraacetic acid,mops, 3-(n-morpholino)propanesulfonic acid,fis1, mitochondrial fission 1 protein,fccp, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone,fbs, fetal bovine serum,hepes, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid,ndufb8, nadh dehydrogenase (ubiquinone) 1 beta subcomplex, 8,np-40, noniodet p40,lc3, (microtubule-associated protein 1 light chain 3),opa1, optic atrophy 1,pcna, proliferating cell nuclear antigen,pdgf-bb, platelet-derived growth factor-bb,pvdf, polyvinylidene fluoride,sds, sodium dodecyl sulfate,sdhb, succinate dehydrogenase subunit b,tmpd, n,n,n′,n′-tetramethyl-p-phenylenediamine,vsmc, vascular smooth muscle cells,metabolism,oxidative phosphorylation,restenosis,atherosclerosis,fusion,extracellular flux

                Comments

                Comment on this article